statistiche ricercatore

Continente	#
NA - Nord America	842
AS - Asia	753
EU - Europa	465
SA - Sud America	38
Continente sconosciuto - Info sul continente non disponibili	38
AF - Africa	26
Totale	2.162

Nazione	#
US - Stati Uniti d'America	811
CN - Cina	185
SG - Singapore	184
VN - Vietnam	157
HK - Hong Kong	127
GB - Regno Unito	111
SE - Svezia	86
DE - Germania	61
IT - Italia	47
FR - Francia	32
IN - India	26
BR - Brasile	25
UA - Ucraina	25
RU - Federazione Russa	20
IE - Irlanda	18
KR - Corea	17
NL - Olanda	17
CA - Canada	14
CI - Costa d'Avorio	11
JO - Giordania	11
JP - Giappone	11
FI - Finlandia	8
MX - Messico	8
ZA - Sudafrica	8
BE - Belgio	7
CH - Svizzera	7
HR - Croazia	7
EE - Estonia	6
AR - Argentina	5
ID - Indonesia	5
PL - Polonia	5
TW - Taiwan	5
BD - Bangladesh	4
PH - Filippine	4
TH - Thailandia	4
CR - Costa Rica	3
EC - Ecuador	3
ES - Italia	3
AT - Austria	2
CO - Colombia	2
HN - Honduras	2
IR - Iran	2
MY - Malesia	2
NG - Nigeria	2
SA - Arabia Saudita	2
TG - Togo	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
BG - Bulgaria	1
BO - Bolivia	1
BS - Bahamas	1
CM - Camerun	1
CU - Cuba	1
GR - Grecia	1
IQ - Iraq	1
JM - Giamaica	1
KN - Saint Kitts e Nevis	1
LK - Sri Lanka	1
MA - Marocco	1
OM - Oman	1
PK - Pakistan	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SC - Seychelles	1
TR - Turchia	1
UY - Uruguay	1
Totale	2.125

Nome	#
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium	298
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.	273
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.	218
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience	217
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.	215
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.	166
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.	163
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma	163
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine	160
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.	157
null	97
Gemcitabine	35
Totale	2.162

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	177	0	0	0	27	18	10	3	12	7	19	49	32
2022/2023	278	39	24	11	29	22	22	4	14	68	4	20	21
2023/2024	43	3	9	2	7	6	10	1	2	0	2	0	1
2024/2025	228	2	31	11	13	34	8	12	2	4	25	12	74
2025/2026	760	47	55	57	44	155	74	71	19	145	49	38	6
2026/2027	98	16	19	52	11	0	0	0	0	0	0	0	0
Totale													2.162

CRIS Current Research Information System